MIT researchers have shown that cells from different people don't all react the same way when exposed to the same DNA-damaging agent, a finding that could help clinicians predict how patients will…

GENEVA, Switzerland, September 18 /PRNewswire/ -- - ORACLE MS Phase III Trial Will Assess Effectiveness of Cladribine Tablets in Preventing Conversion to Definite Multiple Sclerosis in Addition to…

AMSTERDAM, The Netherlands, September 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license…

Biologists at the University of Rochester writing in Aging Cell have found that small-bodied rodents with long lifespans have evolved a previously unknown anti-cancer mechanism that appears to be…

Skin cancer is the most common malignancy in the US, says the American Academy of Dermatology, and one American dies every 62 minutes from melanoma. The WHO estimated that, in the year 2000, up to 71…

FRIMLEY, England, September 17 /PRNewswire/ -- - New data, updated since ASCO, show time without tumour growth now reaches nearly 5 months with RAD001 vs. 1.9 months with placebo(1) - One quarter of…

SOUTHAMPTON, England, September 17 /PRNewswire/ -- Global leader in personal satellite navigation (PND) Garmin is proud to be the headline sponsor of the 2008 Garmin T3 Gadget Awards. The awards,…

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The…

GENEVA, Switzerland, September 17 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX trial (REbif…

Scientists from IBM and the Genome Institute of Singapore (GIS) say their report in Nature shows that microRNAs, those small molecules that are an important regulatory component in the machinery of…